Pieris Pharmaceuticals to Present at Investor Conferences in March
BOSTON, MA--(Marketwired - March 06, 2018) - Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin® technology platform for cancer, respiratory and other …